|
EP0348523A4
(en)
|
1987-12-22 |
1991-10-09 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compounds and their medicinal use
|
|
DE69017302T3
(de)
|
1989-08-04 |
1999-08-05 |
Merck Sharp & Dohme Ltd., Hoddesdon, Hertfordshire |
Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten.
|
|
US5399565A
(en)
|
1990-07-17 |
1995-03-21 |
Eli Lilly And Company |
Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
|
|
AU656754B2
(en)
|
1990-12-25 |
1995-02-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel benzodiazepine derivative
|
|
CA2110986A1
(en)
|
1991-07-12 |
1993-01-21 |
Geoffrey Neil Woodruff |
Cholecystokinin antagonists useful in the treatment of panic attacks
|
|
JP3239364B2
(ja)
*
|
1991-10-11 |
2001-12-17 |
ウェルファイド株式会社 |
骨粗鬆症治療薬およびジアゼピン化合物
|
|
WO1993012817A1
(en)
*
|
1991-12-20 |
1993-07-08 |
Warner-Lambert Company |
Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
|
|
IL104853A
(en)
|
1992-02-27 |
1997-11-20 |
Yamanouchi Pharma Co Ltd |
Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
|
|
JP3419539B2
(ja)
|
1993-02-17 |
2003-06-23 |
中外製薬株式会社 |
インドリン−２−オン誘導体
|
|
GB2282595A
(en)
|
1993-08-25 |
1995-04-12 |
Yamanouchi Pharma Co Ltd |
Benzodiazepine derivatives
|
|
IT1261255B
(it)
|
1993-09-09 |
1996-05-09 |
Rotta Research Lab |
Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico.
|
|
AU715611B2
(en)
|
1995-12-11 |
2000-02-03 |
New England Medical Center Hospitals, Inc., The |
Assay for and uses of peptide hormone receptor ligands
|
|
US5750353A
(en)
|
1995-12-11 |
1998-05-12 |
New England Medical Center Hospitals, Inc. |
Assay for non-peptide agonists to peptide hormone receptors
|
|
US5922883A
(en)
|
1996-04-03 |
1999-07-13 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US20040001842A1
(en)
|
1997-05-12 |
2004-01-01 |
Dov Michaeli |
Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
|
|
US6548066B1
(en)
|
1997-05-12 |
2003-04-15 |
Aphton Corporation |
Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
|
|
KR100699574B1
(ko)
|
1998-05-15 |
2007-03-23 |
리셉터 바이오로직스 인크 |
종양 치료를 위한 조합 치료
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AU4231299A
(en)
|
1998-06-04 |
1999-12-20 |
Abbott Laboratories |
Cell adhesion-inhibiting antinflammatory compounds
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
EP1156037B1
(en)
|
1999-01-29 |
2004-12-01 |
Chugai Seiyaku Kabushiki Kaisha |
Chondrongenesis promotors and indolin-2-one derivatives
|
|
HK1045306A1
(zh)
|
1999-06-03 |
2002-11-22 |
Abbott Laboratories |
抑制细胞黏附的抗炎化合物
|
|
US20030191279A1
(en)
|
1999-08-27 |
2003-10-09 |
Goldstein Steven Wayne |
Urea derivatives useful as anticancer agents
|
|
US6844367B1
(en)
|
1999-09-17 |
2005-01-18 |
Millennium Pharmaceuticals, Inc. |
Benzamides and related inhibitors of factor Xa
|
|
ES2259617T3
(es)
|
1999-11-05 |
2006-10-16 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Compuestos heterociclicos y su aplicacion como medicamentos.
|
|
AU3003701A
(en)
|
1999-11-19 |
2001-05-30 |
Axxima Pharmaceuticals Ag |
Inhibitors of helicobacter pylori induced gastrointestinal diseases
|
|
AU2001253024A1
(en)
|
2000-04-10 |
2001-10-23 |
The General Hospital Corporation |
Diagnosis and treatment of gastrointestinal disease
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
CA2441228A1
(en)
|
2001-03-23 |
2002-10-03 |
Aphton Corporation |
Combination treatment of pancreatic cancer
|
|
US20040138285A1
(en)
|
2001-04-27 |
2004-07-15 |
Makoto Okazaki |
Chondrogenesis promoters
|
|
US20090191232A1
(en)
|
2001-05-04 |
2009-07-30 |
Gevas Philip C |
Combination therapy for the treatment of tumors
|
|
JPWO2002092096A1
(ja)
|
2001-05-11 |
2004-08-26 |
山之内製薬株式会社 |
抗腫瘍剤
|
|
AUPR738301A0
(en)
|
2001-08-30 |
2001-09-20 |
Starpharma Limited |
Chemotherapeutic agents
|
|
IL161330A0
(en)
|
2001-11-13 |
2004-09-27 |
Black James Foundation |
Benzotriazepines as gastrin and cholecystokinin receptor ligands
|
|
ES2281633T3
(es)
|
2002-02-19 |
2007-10-01 |
Pfizer Italia S.R.L. |
Derivados triciclicos de pirazol, procedimiento para su preparacion y su uso como agentes antitumorales.
|
|
DE10207037A1
(de)
|
2002-02-20 |
2003-08-28 |
Bayer Cropscience Gmbh |
2-Amino-4-bicyclyamino-6H-1,3.5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
UA79804C2
(en)
|
2002-07-03 |
2007-07-25 |
Janssen Pharmaceutica Nv |
Cck-1 receptor modulators
|
|
US20030049698A1
(en)
|
2002-10-08 |
2003-03-13 |
Wang Timothy C. |
Diagnosis and treatment of gastrointestinal disease
|
|
MXPA05010484A
(es)
|
2003-03-28 |
2006-03-10 |
Johnson & Johnson |
Compuestos de benzo[1,2,5]tiadiazole.
|
|
GB0310865D0
(en)
|
2003-05-12 |
2003-06-18 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands
|
|
WO2004101533A1
(en)
|
2003-05-12 |
2004-11-25 |
Janssen Pharmaceutica, N.V. |
1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
|
|
WO2005007107A2
(en)
*
|
2003-07-11 |
2005-01-27 |
University Of Massachusetts |
Histamine and cck2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer
|
|
EP1651621B1
(en)
|
2003-08-08 |
2008-08-06 |
Janssen Pharmaceutica N.V. |
2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators
|
|
US20070293482A1
(en)
|
2004-03-19 |
2007-12-20 |
Novartis Pharmaceuticals Corporation |
Process for Preparing Benzodiazepines
|
|
US7429604B2
(en)
|
2004-06-15 |
2008-09-30 |
Bristol Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
US7947833B2
(en)
|
2004-08-04 |
2011-05-24 |
Janssen Pharmaceutica Nv |
Preparation of quinoxaline compounds
|
|
US7297816B2
(en)
|
2004-09-24 |
2007-11-20 |
Janssen Pharmaceutica N.V. |
Sulfonamide compounds
|
|
EP1817333A4
(en)
|
2004-10-12 |
2008-12-31 |
Janssen Pharmaceutica Nv |
CHOLECYSTOKININ-1 RECEPTOR MATERIALS OF DOGS AND THEIR USE
|
|
CA2575764A1
(en)
|
2004-10-27 |
2006-05-11 |
Neurogen Corporation |
Diaryl ureas as cb1 antagonists
|
|
US20080009477A1
(en)
|
2004-11-04 |
2008-01-10 |
Neurogen Corporation |
Arylalkyl Ureas As Cb1 Antagonists
|
|
GB0425196D0
(en)
|
2004-11-15 |
2004-12-15 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands
|
|
EA011512B1
(ru)
|
2004-12-17 |
2009-04-28 |
Ракуалиа Фарма Инк. |
Производные хромана, полезные в качестве антагонистов кислотной помпы
|
|
PL1839662T3
(pl)
|
2005-01-19 |
2010-08-31 |
Zeria Pharm Co Ltd |
Środek przeciwnowotworowy
|
|
AR053713A1
(es)
|
2005-04-20 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos como agentes terapeuticos
|
|
ES2423412T3
(es)
|
2005-06-06 |
2013-09-20 |
The Board Of Trustees Of The University Of Illinois |
Composiciones y métodos para tratar los trastornos del sueño
|
|
JP2008543824A
(ja)
|
2005-06-14 |
2008-12-04 |
ファイザー株式会社 |
アシッドポンプアンタゴニストとしてのクロマン置換ベンゾイミダゾール誘導体
|
|
ATE425791T1
(de)
|
2005-07-29 |
2009-04-15 |
Rottapharm Spa |
Kombination aus itriglumid und ppi zur behandlung von gastrointestinalen- und assozierten krankheiten
|
|
WO2007026218A2
(en)
|
2005-09-01 |
2007-03-08 |
Pfizer Japan Inc. |
Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
|
|
WO2007031860A1
(en)
|
2005-09-15 |
2007-03-22 |
Pfizer Japan Inc. |
Indane substituted benzimidazoles and their use as acid pump inhibitors
|
|
WO2007072146A1
(en)
|
2005-12-19 |
2007-06-28 |
Pfizer Japan Inc. |
Chromane substituted benzimidazoles and their use as acid pump inhibitors
|
|
WO2007072142A2
(en)
|
2005-12-19 |
2007-06-28 |
Pfizer Japan Inc. |
Benzimidazole-5-carboxamide derivatives
|
|
WO2007107827A1
(en)
|
2006-03-17 |
2007-09-27 |
Raqualia Pharma Inc. |
Chromane derivatives
|
|
CA2649000A1
(en)
|
2006-04-12 |
2007-10-18 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
|
|
FR2901472B1
(fr)
|
2006-05-24 |
2010-08-13 |
Oreal |
Procede de defrisage des fibres keratiniques avec un moyen de chauffage et des agents denaturants
|
|
FR2901473B1
(fr)
|
2006-05-24 |
2010-08-13 |
Oreal |
Procede de defrisage des fibres keratiniques avec un moyen de chauffage et une amide
|
|
JP5140080B2
(ja)
|
2006-09-21 |
2013-02-06 |
ラクオリア創薬株式会社 |
選択的アシッドポンプ阻害剤としてのベンゾイミダゾール誘導体
|
|
WO2008046082A2
(en)
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Use of heterocyclic compounds as therapeutic agents
|
|
WO2008059373A1
(en)
|
2006-11-17 |
2008-05-22 |
Raqualia Pharma Inc. |
Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
|
|
JP2008222557A
(ja)
|
2007-03-08 |
2008-09-25 |
Kotobuki Seiyaku Kk |
ピロロ［３，２−ｄ］ピリミジン誘導体及びこれを有効成分とする医薬組成物
|
|
WO2008114123A1
(en)
|
2007-03-21 |
2008-09-25 |
Raqualia Pharma Inc. |
Spiro benzimidazole derivatives as acid pump inhibitors
|
|
WO2008124524A2
(en)
|
2007-04-03 |
2008-10-16 |
Janssen Pharmaceutica N.V. |
Aryl sulfonamide compounds as modulators of the cck2 receptor
|
|
WO2008124518A1
(en)
|
2007-04-03 |
2008-10-16 |
Janssen Pharmaceutica N.V. |
Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
|
|
WO2009000413A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
RU2379043C2
(ru)
|
2007-08-02 |
2010-01-20 |
Закрытое акционерное общество "Биологические исследования и системы" |
Фармацевтическая композиция для профилактики и лечения остеопороза у женщин в период менопаузы
|
|
US20110105515A1
(en)
|
2007-08-07 |
2011-05-05 |
President And Fellows Of Harvard College |
Targeting the oncoprotein nucleophosmin
|
|
AR073578A1
(es)
|
2008-09-15 |
2010-11-17 |
Priaxon Ag |
Pirrolidin-2-onas
|
|
WO2010036316A1
(en)
|
2008-09-24 |
2010-04-01 |
Yangbo Feng |
Urea and carbamate compounds and analogs as kinase inhibitors
|
|
CN102333763A
(zh)
|
2009-03-31 |
2012-01-25 |
善利亚新药工业股份有限公司 |
1,5-苯二氮䓬衍生物的制备方法
|
|
EP2452680B1
(en)
|
2009-07-09 |
2019-12-18 |
RaQualia Pharma Inc. |
Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
|
|
WO2011036461A1
(en)
|
2009-09-24 |
2011-03-31 |
Centro Nacional De Investigaciones Oncόlogicas (Cnio) |
Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors
|
|
PL2485731T4
(pl)
|
2009-10-06 |
2017-07-31 |
Millennium Pharmaceuticals, Inc. |
Związki heterocykliczne użyteczne jako inhibitory PDK1
|
|
EP2499195B1
(en)
|
2009-11-13 |
2020-12-09 |
Plastipak Packaging, Inc. |
Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
|
|
WO2011063164A2
(en)
|
2009-11-18 |
2011-05-26 |
Steady Sleep Rx Co., Inc. |
Sustained release cannabinoid medicaments
|
|
EP2560656A4
(en)
|
2010-04-23 |
2013-11-27 |
Kineta Inc |
ANTIVIRAL CONNECTIONS
|
|
CN103153096B
(zh)
|
2010-08-12 |
2016-08-03 |
赛诺米克斯公司 |
提高甜味增强剂的稳定性的方法和包含稳定的甜味增强剂的组合物
|
|
BR112013012468A2
(pt)
|
2010-11-18 |
2016-09-06 |
Pier Pharmaceuticals |
método de tratar um indivíduo com um distúrbio sensível a canabinóide, de estabelecer uma dose ideal, de tratar um indivíduo com um distúrbio de apneia do sono, e, kit
|
|
US20120231083A1
(en)
|
2010-11-18 |
2012-09-13 |
The Board Of Trustees Of The University Of Illinois |
Sustained release cannabinoid medicaments
|
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
|
WO2013017480A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
WO2013017479A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
ES2736603T3
(es)
|
2011-11-07 |
2020-01-03 |
Massachusetts Inst Technology |
Complejos de wolframio oxo alquilideno para la metátesis de olefinas selectiva de Z
|
|
WO2013126797A1
(en)
|
2012-02-24 |
2013-08-29 |
Purdue Research Foundation |
Cholecystokinin b receptor targeting for imaging and therapy
|
|
WO2013158928A2
(en)
|
2012-04-18 |
2013-10-24 |
Elcelyx Therapeutics, Inc. |
Chemosensory receptor ligand-based therapies
|
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
|
US8952009B2
(en)
|
2012-08-06 |
2015-02-10 |
Amgen Inc. |
Chroman derivatives as TRPM8 inhibitors
|